Clinical trial
Oral Probiotics (Infloran®) for Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Infants
NCT01751477 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Probiotics (Infloran®) for Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Infants
- Lead sponsor
- Medical University of Vienna
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- October 31, 2012
- Enrollment
- 463 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
necrotizing enterocolitis